Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

908 Devices (MASS) Current Deferred Revenue (2020 - 2025)

908 Devices (MASS) has disclosed Current Deferred Revenue for 6 consecutive years, with $8.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Current Deferred Revenue fell 14.24% to $8.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $8.9 million, a 14.24% decrease, with the full-year FY2025 number at $8.9 million, down 14.24% from a year prior.
  • Current Deferred Revenue was $8.9 million for Q4 2025 at 908 Devices, down from $18.3 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $22.5 million in Q3 2024 to a low of $8.8 million in Q2 2025.
  • A 5-year average of $14.8 million and a median of $15.9 million in 2022 define the central range for Current Deferred Revenue.
  • Peak YoY movement for Current Deferred Revenue: surged 373.11% in 2021, then plummeted 53.63% in 2025.
  • 908 Devices' Current Deferred Revenue stood at $14.5 million in 2021, then increased by 13.7% to $16.5 million in 2022, then rose by 3.6% to $17.1 million in 2023, then plummeted by 39.1% to $10.4 million in 2024, then decreased by 14.24% to $8.9 million in 2025.
  • Per Business Quant, the three most recent readings for MASS's Current Deferred Revenue are $8.9 million (Q4 2025), $18.3 million (Q3 2025), and $8.8 million (Q2 2025).